Frederick W. Driscoll
2016 - Flexion Therapeutics
In 2016, Frederick W. Driscoll earned a total compensation of $2.2M as Chief Financial Officer at Flexion Therapeutics, a 59% increase compared to previous year.
Compensation breakdown
| Bonus | $154,000 |
|---|---|
| Option Awards | $1,656,000 |
| Salary | $350,000 |
| Other | $22,538 |
| Total | $2,182,538 |
Driscoll received $1.7M in option awards, accounting for 76% of the total pay in 2016.
Driscoll also received $154K in bonus, $350K in salary and $22.5K in other compensation.
Rankings
In 2016, Frederick W. Driscoll's compensation ranked 4,493rd out of 14,075 executives tracked by ExecPay. In other words, Driscoll earned more than 68.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,493 out of 14,075 | 68th |
Division Manufacturing | 1,588 out of 5,486 | 71st |
Major group Chemicals And Allied Products | 486 out of 1,900 | 74th |
Industry group Drugs | 357 out of 1,543 | 77th |
Industry Pharmaceutical Preparations | 280 out of 1,173 | 76th |
Source: SEC filing on April 28, 2017.
Driscoll's colleagues
We found two more compensation records of executives who worked with Frederick W. Driscoll at Flexion Therapeutics in 2016.